KOE:000250

Sam Chun Dang Pharm. Co., Ltd · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:25 UTC

Last close

n/aKRW

Market data

751.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
3.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-15.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.25Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

What it pays out is the furthest below its sector's middle: 0.09 against 0.54 on the market's range.

Five bars, one line

lens 7 of 9

1.29x

4.14x

4.28x

1.81x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales1.29x
Its own average over 10 years, 180.14B.
Profit4.14x
Its own average over 10 years, 1.27B.
Free cash flow4.28x
Its own average over 10 years, -8.49B.
Debt1.81x
Its own average over 10 years, 38.49B.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 4.28 times.

Sales is 1.29 times its own 10-year average; Profit is 4.14 times its own 10-year average; Free cash flow is 4.28 times its own 10-year average; Debt is 1.81 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 10-year average1.29
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Profit against its own 10-year average4.14
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Free cash flow against its own 10-year average4.28
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Debt against its own 10-year average1.81
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
KRW